Cargando…
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
BACKGROUND: Schizophrenia is a chronic and debilitating disorder, the etiology of which remains unclear. Apoptosis is a programmed cell death mechanism that might be implicated in neuropsychiatric disorders, including schizophrenia. In this study, we aimed to compare the serum levels of apoptosis am...
Autores principales: | Beyazyüz, Murat, Küfeciler, Tarkan, Bulut, Leyla, Ünsal, Cüneyt, Albayrak, Yakup, Akyol, Esra Soydaş, Baykal, Saliha, Kuloglu, Murat, Hashimoto, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889085/ https://www.ncbi.nlm.nih.gov/pubmed/27307738 http://dx.doi.org/10.2147/NDT.S106993 |
Ejemplares similares
-
Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia
por: Albayrak, Yakup, et al.
Publicado: (2015) -
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
por: Akyol, Esra Soydaş, et al.
Publicado: (2015) -
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
por: Ünsal, Cüneyt, et al.
Publicado: (2013) -
Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia
por: Beyazyüz, Murat, et al.
Publicado: (2014) -
Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study
por: Beyazyüz, Murat, et al.
Publicado: (2013)